Revvity Inc. Common Stock (RVTY)

About RVTY

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in…

Sector

Industrials

Industry

Biotechnology: Laboratory Analytical Instruments

Employees

11,000

Website

www.revvity.com/

Fundamentals

1-day range

$115.29$122.11

Market cap

$12.74B

P/E (trailing)

55.10

P/E (forward)

20.27

EPS (trailing)

$2.10

Dividend yield

0.31%

Beta

1.10

Avg. volume

1.49M

Ex-dividend date

October 23, 2026

Dividend pay date

November 13, 2026

Forecasts

15 analyst ratings

Revvity Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• RVTY

  Revvity Inc. Common Stock

  $128.8

  ▼ 0.70%
  Market cap $12.74BP/E 55.10
  $81.22$129.8
• TXG

  10x Genomics Inc. Class A Common Stock

  $61.55

  ▼ 5.10%
  Market cap $5.79BP/E —
  $11.16$66.94
• ALMR

  Alamar Biosciences Inc. Common Stock

  $30.71

  ▼ 6.94%
  Market cap $1.95BP/E —
  $18.85$38.54
• EYPT

  EyePoint Inc. Common Stock

  $4.47

  ▼ 3.46%
  Market cap $1.08BP/E —
  $3.95$19.11
• CTKB

  Cytek Biosciences Inc. Common Stock

  $4.69

  ▲ 1.41%
  Market cap $537.23MP/E —
  $3.28$6.18
• PACB

  Pacific Biosciences of California Inc. Common Stock

  $1.4

  ▼ 10.00%
  Market cap $361.85MP/E —
  $1.07$2.73
• QTRX

  Quanterix Corporation Common Stock

  $2.64

  ▼ 0.00%
  Market cap $180.42MP/E —
  $2.15$8.77

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Exploring the top movers within the S&P500 index during today's session.
  ChartMill · 8/20/2026
• Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside
  SeekingAlpha · 8/16/2026
• Danaher: 2027 Growth Reacceleration Should Drive Upside
  SeekingAlpha · 8/14/2026
• Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs
  Yahoo · 8/13/2026
• The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call
  Yahoo · 8/13/2026
• Revvity (RVTY) Q2 2026 Earnings Call Transcript
  Yahoo · 8/11/2026
• Revvity to Present at Upcoming Investor Conferences
  Yahoo · 8/11/2026
• Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing
  Yahoo · 8/10/2026

• Alexis P. Michas · August 25, 2026 · Gift

  285
• Anita Gonzales · July 20, 2026 · Sale

  85 @ $109.48
• Michelle McMurry-Heath · May 7, 2026 · Grant

  1.3K
• Michelle McMurry-Heath · May 7, 2026 · Grant

  1.0K
• Michael A. Klobuchar · May 7, 2026 · Grant

  1.3K
• Michael A. Klobuchar · May 7, 2026 · Grant

  1.0K
• Pascale Witz · May 7, 2026 · Grant

  1.3K
• Pascale Witz · May 7, 2026 · Grant

  1.0K
• Samuel R. Chapin · May 7, 2026 · Grant

  1.3K
• Samuel R. Chapin · May 7, 2026 · Grant

  1.0K
• Michel Vounatsos · May 7, 2026 · Grant

  1.3K
• Michel Vounatsos · May 7, 2026 · Grant

  1.0K
• Frank Witney · May 7, 2026 · Grant

  1.3K
• Frank Witney · May 7, 2026 · Grant

  1.0K
• Sophie Vandebroek V · May 7, 2026 · Grant

  1.3K

Institutional Ownership

March 31, 2026

Total shares held

110.08M

Total value held

$6.77B

Institutional holders

494